Profund Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
4,063
+180
| +5% | +$18.8K | 0.02% | 523 |
|
|
2025
Q1 | $453K | Sell |
3,883
-1,003
| -21% | -$117K | 0.02% | 505 |
|
|
2024
Q4 | $413K | Sell |
4,886
-730
| -13% | -$61.8K | 0.02% | 606 |
|
|
2024
Q3 | $505K | Sell |
5,616
-1,255
| -18% | -$113K | 0.02% | 526 |
|
|
2024
Q2 | $553K | Sell |
6,871
-2,144
| -24% | -$173K | 0.02% | 472 |
|
|
2024
Q1 | $719K | Buy |
9,015
+701
| +8% | +$55.9K | 0.03% | 453 |
|
|
2023
Q4 | $662K | Buy |
8,314
+181
| +2% | +$14.4K | 0.03% | 432 |
|
|
2023
Q3 | $568K | Sell |
8,133
-711
| -8% | -$49.7K | 0.03% | 432 |
|
|
2023
Q2 | $636K | Sell |
8,844
-1,681
| -16% | -$121K | 0.03% | 431 |
|
|
2023
Q1 | $649K | Buy |
10,525
+7,416
| +239% | +$457K | 0.04% | 423 |
|
|
2022
Q4 | $240K | Buy |
+3,109
| New | +$240K | 0.02% | 778 |
|
|
2020
Q3 | – | Sell |
-2,464
| Closed | -$203K | – | 972 |
|
|
2020
Q2 | $203K | Buy |
+2,464
| New | +$203K | 0.01% | 821 |
|
|
2020
Q1 | – | Sell |
-2,680
| Closed | -$277K | – | 812 |
|
|
2019
Q4 | $277K | Buy |
+2,680
| New | +$277K | 0.01% | 974 |
|